UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
about
Blood pressure control for diabetic retinopathyBlood pressure control for diabetic retinopathyAnatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trialsCirculating Biomarkers of Diabetic Retinopathy: An Overview Based on PhysiopathologyEpidemiology of diabetic retinopathy, diabetic macular edema and related vision lossCurrent trends in the monitoring and treatment of diabetic retinopathy in young adultsEpidemiological issues in diabetic retinopathyThe Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both?Does cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrhage in diabetic eye disease?Progression and regression: distinct developmental patterns of diabetic retinopathy in patients with type 2 diabetes treated in the diabetes care system west-friesland, the Netherlands.Concordance of retinopathy and nephropathy over time in Type 1 diabetes: an analysis of data from the Diabetes Control and Complications Trial.Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study.Identification of independent risk factors for the development of diabetic retinopathy requiring treatment.The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark.Comorbidity in patients with diabetes mellitus: impact on medical health care utilizationLaser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema.Comparison of information content of structured and narrative text data sources on the example of medication intensificationPrevalence of diabetic retinopathy and cataract in adult patients with type 1 and type 2 diabetes in Russia.Why do patients still require surgery for the late complications of Proliferative Diabetic Retinopathy?Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme.Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye diseaseOptimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy.Body mass index and risk of diabetic retinopathy: A meta-analysis and systematic review.Short wavelength automated perimetry can detect visual field changes in diabetic patients without retinopathy.An association between subclinical hypothyroidism and sight-threatening diabetic retinopathy in type 2 diabetic patients.Prevalence and progression of visual impairment in patients newly diagnosed with clinical type 2 diabetes: a 6-year follow up study.Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control aloneEffect of trandolapril on regression of retinopathy in hypertensive patients with type 2 diabetes: a prespecified analysis of the benedict trial.Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.Prevalence of retinopathy among adults with self-reported diabetes mellitus: the Sri Lanka diabetes and Cardiovascular StudyPrevalence and determinants of diabetic retinopathy in Al hasa region of saudi arabia: primary health care centre based cross-sectional survey, 2007-2009.Prevalence of diabetic retinopathy in the United States, 2005-2008.Retinopathy risk factors in type II diabetic patients using factor analysis and discriminant analysis.Diabetic hypertensive control and treatment: a descriptive report from the audit diabetes control and management (adcm) registryCan the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy?A microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patientsEpidemiology of diabetic retinopathy and macular oedema: a systematic review.Laser refractive surgery in diabetic patients: a review of the literature.The 5-year onset and regression of diabetic retinopathy in Chinese type 2 diabetes patients.
P2860
Q24186434-14CF722E-B453-4C40-968A-EDA23025828FQ24245872-BF04D453-9996-40CB-B67C-3D8DC7165FCFQ24658545-387FEBF0-BB85-456D-AAC8-028BA0D9403EQ26744760-870F251D-C80C-4ED8-B4D0-267A05BE09B2Q26775552-03923114-9324-4A39-94EE-F421FD4FE1EBQ26863388-82CF6A5E-1603-4F49-9D0F-F6749D08B63EQ27003941-D9B2DF40-D430-43B2-81F0-7EA3ED5EF4E5Q28075888-9F917908-A760-49DC-8743-E0E757E1385BQ28167359-2383D04F-C299-455E-8BC9-1F2DC7A38A52Q30499098-756D4E17-1B8B-44BB-88A9-D27CB1A41726Q30658906-AD712ADD-60F9-4195-9CD7-6DBD68443B60Q30854998-42A2A3E7-EB13-4928-86AF-F321C3A9305EQ30884549-D0FBB165-44AD-457A-B97C-9F635D95F5B0Q31104469-B4BAADBD-8555-4592-9136-8155D909356CQ33248806-EC605A8E-9A9E-4C84-9FD8-D32D49EF58C7Q33282848-99DB3D01-D5FA-4C8B-96F6-7CDBB88A19D7Q33414983-152629E9-EC20-4981-B689-DB43755C2D04Q33508839-7802949B-226A-4F10-B5A1-2F92FF1AF975Q33522560-7CC7BD71-B5E7-4736-85F0-35F1CAE79424Q33602366-725D4900-28CD-4D5E-8DEB-AD4DDB272FE8Q33659440-F56904CC-19AF-462F-B56B-825BFD22F70CQ33705724-66F1199A-A198-456D-97C3-D96C184FBBB0Q33740088-08DE3DDB-141D-4583-9CC3-7532BB661352Q33765398-7FA3EDF1-5642-4657-A3B8-5899ABC7C4C6Q33780618-493F5252-012A-42D6-9793-A296E357CF62Q33804574-7C49F304-1EAC-46FA-96FD-8DCB8591AF90Q33812061-1CA0166C-65EC-4D09-90DC-D19284555343Q33853527-BEF3DA5B-FB56-4E61-970F-855A184F014DQ33982971-C4A21470-6045-4057-9F92-C73E53EDAE6AQ34008233-AA483503-86BE-41B9-84CB-76B7AD051BE3Q34076715-8841A82A-593C-4421-86CB-F9B37E31DB8FQ34107549-4E57FC55-F61B-48F4-8BA1-0AF255EB97C0Q34154127-396F3318-6229-4D3E-8D35-1EB9F3740CA0Q34192508-9E242E2D-2CAC-4FF2-A025-9EBF4AA5AB27Q34220846-DC70EFAC-0AF3-4268-A73B-912058264465Q34261308-C05385C4-201F-4D1F-BC1E-79450DB1CF2DQ34270942-DFEC6D30-4F97-470A-8E4B-92BCFD6E3202Q34330907-E096101C-CF10-4F25-91A1-6A8D4FD9015DQ34477134-8CBD063F-BBAE-439F-AC0D-CC5BEEC31FDEQ34526936-E8E3172E-8906-4BAC-AA36-9A1072ADAAA6
P2860
UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
UKPDS 50: risk factors for inc ...... s over 6 years from diagnosis.
@en
UKPDS 50: risk factors for inc ...... s over 6 years from diagnosis.
@nl
type
label
UKPDS 50: risk factors for inc ...... s over 6 years from diagnosis.
@en
UKPDS 50: risk factors for inc ...... s over 6 years from diagnosis.
@nl
prefLabel
UKPDS 50: risk factors for inc ...... s over 6 years from diagnosis.
@en
UKPDS 50: risk factors for inc ...... s over 6 years from diagnosis.
@nl
P2093
P356
P1433
P1476
UKPDS 50: risk factors for inc ...... es over 6 years from diagnosis
@en
P2093
Aldington SJ
Matthews DR
P2888
P304
P356
10.1007/S001250051594
P577
2001-02-01T00:00:00Z